A Real-World Study on Pulmonary Arterial Hypertension in Bulgaria: A Single-Center Retrospective Study From 2012 to 2022

Study identification

• EU PAS number:
  EUPAS1000000687
• Study ID:
  1000000687
• Official title and acronym:
  A Real-World Study on Pulmonary Arterial Hypertension in Bulgaria: A Single-Center Retrospective Study From 2012 to 2022
• DARWIN EU® study:
  No
• Study countries:
  Bulgaria
• Study description:
  A Real-World Study on Pulmonary Arterial Hypertension in Bulgaria: A Single-Center Retrospective Study From 2012 to 2022
• Study status:
  Finalised

Research institutions and networks

Institutions

Merck Sharp & Dohme LLC

United States

Study timelines

Date when funding contract was signed

Planned:23/10/2023

Actual:23/10/2023

Study start date

Planned:08/01/2024

Actual:08/01/2024

Date of final study report

Planned:28/06/2024

Actual:28/06/2024

Sources of funding

Pharmaceutical company and other private sector 

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable

Other study registration identification numbers and links

A Real-World Study on Pulmonary Arterial Hypertension in Bulgaria: A Single-Cen…